162 related articles for article (PubMed ID: 21628926)
1. Predictive value of the fibrosis scores in patients with chronic hepatitis C associated with liver fibrosis and metabolic syndrome.
Miyaaki H; Ichikawa T; Taura N; Miuma S; Shibata H; Isomoto H; Takeshima F; Nakao K
Intern Med; 2011; 50(11):1137-41. PubMed ID: 21628926
[TBL] [Abstract][Full Text] [Related]
2. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.
Leandro G; Mangia A; Hui J; Fabris P; Rubbia-Brandt L; Colloredo G; Adinolfi LE; Asselah T; Jonsson JR; Smedile A; Terrault N; Pazienza V; Giordani MT; Giostra E; Sonzogni A; Ruggiero G; Marcellin P; Powell EE; George J; Negro F;
Gastroenterology; 2006 May; 130(6):1636-42. PubMed ID: 16697727
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.
El Ray A; Asselah T; Moucari R; El Ghannam M; Taha AA; Saber MA; Akl M; Atta R; Shemis M; Radwan AS; Ghali A; Paradis V; Marcellin P
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):421-7. PubMed ID: 23470266
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
[TBL] [Abstract][Full Text] [Related]
6. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
7. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infection.
Ahmed AM; Hassan MS; Abd-Elsayed A; Hassan H; Hasanain AF; Helmy A
Saudi J Gastroenterol; 2011; 17(4):245-51. PubMed ID: 21727730
[TBL] [Abstract][Full Text] [Related]
9. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol.
Monto A; Alonzo J; Watson JJ; Grunfeld C; Wright TL
Hepatology; 2002 Sep; 36(3):729-36. PubMed ID: 12198667
[TBL] [Abstract][Full Text] [Related]
10. Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations.
Petta S; Torres D; Fazio G; Cammà C; Cabibi D; Di Marco V; Licata A; Marchesini G; Mazzola A; Parrinello G; Novo S; Licata G; Craxì A
Hepatology; 2012 May; 55(5):1317-23. PubMed ID: 22135089
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis.
Miyaaki H; Ichikawa T; Nakao K; Yatsuhashi H; Furukawa R; Ohba K; Omagari K; Kusumoto Y; Yanagi K; Inoue O; Kinoshita N; Ishibashi H; Yano M; Eguchi K
Liver Int; 2008 Apr; 28(4):519-24. PubMed ID: 17976158
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis.
Amarapurka DN; Amarapurkar AD; Patel ND; Agal S; Baigal R; Gupte P; Pramanik S
Ann Hepatol; 2006; 5(1):30-3. PubMed ID: 16531962
[TBL] [Abstract][Full Text] [Related]
14. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
[TBL] [Abstract][Full Text] [Related]
15. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus.
Brandman D; Pingitore A; Lai JC; Roberts JP; Ferrell L; Bass NM; Terrault NA
Liver Transpl; 2011 Dec; 17(12):1380-6. PubMed ID: 21770018
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS
Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans.
Hu KQ; Currie SL; Shen H; Cheung RC; Ho SB; Bini EJ; McCracken JD; Morgan T; Bräu N; Schmidt WN; Jeffers L; Wright TL;
Dig Dis Sci; 2007 Feb; 52(2):570-8. PubMed ID: 17226072
[TBL] [Abstract][Full Text] [Related]
18. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
[TBL] [Abstract][Full Text] [Related]
19. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
Saadoun D; Asselah T; Resche-Rigon M; Charlotte F; Bedossa P; Valla D; Piette JC; Marcellin P; Cacoub P
Hepatology; 2006 Jun; 43(6):1337-45. PubMed ID: 16729318
[TBL] [Abstract][Full Text] [Related]
20. Obesity and non-alcoholic fatty liver disease in chronic hepatitis C.
Younossi ZM; McCullough AJ; Ong JP; Barnes DS; Post A; Tavill A; Bringman D; Martin LM; Assmann J; Gramlich T; Mullen KD; O'Shea R; Carey WD; Ferguson R
J Clin Gastroenterol; 2004 Sep; 38(8):705-9. PubMed ID: 15319656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
